Abstract
Under a previously approved institutional review board protocol for prostate cancer patients, implanted metal-oxide semiconductor field-effect transistor dosimeters (dose verification system, Sicel Technologies) were used for measurement of the in vivo delivered daily dose. This dosimetric information provided the ability to adapt the plan if the measured doses did not match the dose expected from the planning system. Due to the inherent uncertainty in the dosimeters, the decision to adapt the treatment plan was made only if readings differed by more than 7 % for three consecutive days. To validate this method, we acquired daily cone beam computed tomography images for five patients, and the dose delivered to the dosimeters was calculated by use of (1) an automated procedure (MIM Maestro, MIM Software) and (2) the treatment planning system (XIO, Elekta). 72 % of the doses calculated automatically fell within 1 % of the doses calculated in the planning system, and 99 % agreed within 2 %. When compared to the calculated dose, 53 % of the in vivo measurements fell within 3 % of the calculated dose, 80 % fell within 5 %, and 9.8 % were greater than 7 %, but never on three consecutive days. The measured doses agreed reasonably well with the calculated doses, supporting the decision to adapt the plan only if there were discrepancies of more than 7 % over three consecutive days. Even with the inherent uncertainty in the dosimeters, this adaptive planning method can detect delivery inaccuracies that would not otherwise be caught with the use of only daily image guidance or other dose calculation surrogates.
Similar content being viewed by others
References
Mans A, Wendling M, McDermott LN, et al. Catching errors with in vivo EPID dosimetry. Med Phys. 2010;37:2638–45.
AAPM. Diode in vivo dosimetry for patients receiving external beam radiation therapy. AAPM Report No. 87. Report of task group 62 of the AAPM radiation therapy committee. Madison: Medical Physics Publishing; 2005.
Wu QJ, Thongphiew D, Wang Z, et al. On-line re-optimization of prostate IMRT plans for adaptive radiation therapy. Phys Med Biol. 2008;53:673.
Yan D, Vicini F, Wong J, et al. Adaptive radiation therapy. Phys Med Biol. 1999;42:123.
Tanyi JA, Fuss MH. Volumetric image guidance: Does routine usage prompt adaptive re-planning? An institutional review. Acta Onc. 2008;47(7):1444–53.
Foroudi F, Pham D, Bressel F, Gill S, Kron T. Intrafraction bladder motion in radiation therapy estimated from pretreatment and posttreatment volumetric imaging. Int J Rad Onc Biol Phys. 2013;86(1):77–82.
Richter A, Hu Q, Steglich D, et al. Investigation of the usability of conebeam CT data sets for dose calculation. Rad Onc. 2008; 3(42). http://www.ro-journal.com/content/pdf/1748-717X-3-42.pdf.
Ding GX, Duggan DM, Coffey CW, et al. A study on adaptive IMRT treatment planning using kV cone-beam CT. Radiot Onco. 2007;85:116–25.
Paganelli C, Peroni M, Riboldi M, et al. Scale invariant feature transform in adaptive radiation therapy: a tool for deformable image registration assessment and re-planning indication. Phys Med Biol. 2013;58:287.
Buzurovic I, Showalter TN, Studenski MT, et al. Commissioning and implementation of an implantable dosimeter for radiation therapy. J Appl Clin Med Phys. 2013;14(2):1–19.
Scarantino CW, Rini CJ, Aquino M, et al. Initial clinical results of an in vivo dosimeter during external beam radiation therapy. Int J Radiat Oncol Biol Phys. 2005;62(2):606–13.
Black RD, Scarantino CW, Mann GG, Anscher MS, Ornitz RD, Nelms BE. An analysis of an implantable dosimeter system for external beam therapy. Int J Radiat Oncol Biol Phys. 2005;63(1):290–300.
Beddar AS, Salehpour M, Briere TM, Hamidian H, Gillin MT. Preliminary evaluation of implantable MOSFET radiation dosimeters. Phys Med Biol. 2005;50(1):141–9.
Beyer GP, Scarantino CW, Prestidge BR, et al. Technical evaluation of radiation dose delivered in prostate cancer patients as measured by an implantable MOSFET dosimeter. Int J Radiat Oncol Biol Phys. 2007;69(3):925–35.
Weiss E, Fatyga M, Wu Y, et al. Adaptive radiation therapy with simultaneous integrated volume-adapted boost. Int J Rad Onc Biol Phys. 2013;86(3):414–9.
Nishi T, Nishimura Y, Shibata T, et al. Volume and dosimetric changes and initial clinical experience of a two-step adaptive intensity modulated radiation therapy (IMRT) scheme for head and neck cancer. Radiot Oncol. 2013;106(1):85–9.
Yang C, Liu F, Ahunbay E, et al. Combined online and offline adaptive radiation therapy: a dosimetric feasibility study. Pract Rad Oncol. 2014;4(1):e75–83.
Den RB, Nowak K, Buzurovic I, et al. Implanted dosimeters identify radiation overdose during IMRT for prostate cancer. Int J Rad Onc Biol Phys. 2012;83(3):e371–6.
Studenski MT, Gardner SJ, Pirozzi S, Den RB. Preliminary investigation with in vivo dosimeters into the efficacy of a dose accumulation workflow for adaptive planning [Abstract]. Med Phys. 2013;40:380.
Acknowledgments
The authors would like to thank Sara Pirozzi of MIM Software for her help in implementing the workflow used for the calculation of the daily dose in the CBCT images.
Conflict of interest
None to declare.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Studenski, M.T., Gardner, S.J. & Den, R.B. Uncertainties encountered in implementation of adaptive planning with in vivo dosimeters. Radiol Phys Technol 8, 81–87 (2015). https://doi.org/10.1007/s12194-014-0291-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12194-014-0291-0